
Allena Pharmaceuticals ALNA
Quartalsbericht 2022-Q2
hinzugefügt 15.08.2022
Allena Pharmaceuticals P/E 2011-2025 | ALNA
P/E Jährlich Allena Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | -2.17 | -1.25 | -4.39 | -1.88 | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -1.25 | -4.39 | -2.42 |
P/E anderer Aktien in der Pharmaeinzelhändler
| Name | P/E | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Arbutus Biopharma Corporation
ABUS
|
-6.11 | $ 4.95 | 4.99 % | $ 822 M | ||
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Aclaris Therapeutics
ACRS
|
-1.15 | $ 3.2 | -1.48 % | $ 247 M | ||
|
AlloVir
ALVR
|
-0.833 | - | 4.14 % | $ 49.1 M | ||
|
Aptevo Therapeutics
APVO
|
-0.0368 | $ 1.06 | -5.97 % | $ 293 K | ||
|
Catalyst Biosciences
CBIO
|
-0.393 | $ 13.19 | -6.39 % | $ 868 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Ascendis Pharma A/S
ASND
|
-19.2 | $ 213.99 | -2.92 % | $ 5 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alterity Therapeutics Limited
ATHE
|
-66.5 | $ 3.1 | -5.93 % | $ 7.46 B | ||
|
Celldex Therapeutics
CLDX
|
-0.00833 | $ 27.04 | -1.73 % | $ 1.74 M | ||
|
Corcept Therapeutics Incorporated
CORT
|
46.4 | $ 87.29 | -0.8 % | $ 9.01 B | ||
|
Catalyst Pharmaceuticals
CPRX
|
14.9 | $ 24.46 | 3.56 % | $ 2.9 B | ||
|
CureVac N.V.
CVAC
|
-8.58 | $ 5.04 | -0.3 % | $ 938 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
BioVie
BIVI
|
-0.139 | $ 1.43 | -1.38 % | $ 2.11 M | ||
|
ARCA biopharma
ABIO
|
-5.78 | - | 1052.0 % | $ 415 M | ||
|
Dynavax Technologies Corporation
DVAX
|
63.3 | $ 10.87 | 0.63 % | $ 1.41 B | ||
|
Acasti Pharma
ACST
|
-4.26 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-18 | - | -15.15 % | $ 60.3 M | ||
|
BioNTech SE
BNTX
|
6.11 | $ 94.19 | -0.66 % | $ 27.2 B | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Albireo Pharma
ALBO
|
-15.8 | - | -0.23 % | $ 916 M | ||
|
Alpine Immune Sciences
ALPN
|
-4.65 | - | - | $ 2.17 B | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Amphastar Pharmaceuticals
AMPH
|
8.2 | $ 26.28 | 4.0 % | $ 1.27 B | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Anika Therapeutics
ANIK
|
-4.51 | $ 9.64 | 0.84 % | $ 141 M | ||
|
Eton Pharmaceuticals
ETON
|
-122 | $ 15.96 | -4.43 % | $ 409 M | ||
|
Evogene Ltd.
EVGN
|
-2.18 | $ 1.05 | -2.78 % | $ 27.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-400 | $ 0.27 | -6.29 % | $ 588 M | ||
|
Foghorn Therapeutics
FHTX
|
-2.88 | $ 4.39 | -1.13 % | $ 241 M | ||
|
Arena Pharmaceuticals
ARNA
|
-9.16 | - | -6.81 % | $ 3.04 B | ||
|
Athersys
ATHX
|
-4.62 | - | 3.77 % | $ 22.4 M | ||
|
Acer Therapeutics
ACER
|
-0.463 | - | 2.71 % | $ 14 M | ||
|
Avenue Therapeutics
ATXI
|
-0.0465 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Axon Enterprise
AXON
|
106 | $ 548.77 | -2.75 % | $ 41.6 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
-1.16 | $ 2.36 | 2.61 % | $ 14.8 M | ||
|
AstraZeneca PLC
AZN
|
706 | $ 91.51 | 1.87 % | $ 96.9 B | ||
|
Acorda Therapeutics
ACOR
|
-0.0662 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
-2 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
12.2 | $ 8.95 | -0.56 % | $ 1.45 B | ||
|
BeiGene, Ltd.
BGNE
|
-392 | - | 0.49 % | $ 251 B | ||
|
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
-10.2 | $ 11.28 | -2.17 % | $ 730 M | ||
|
Biogen
BIIB
|
11.9 | $ 174.19 | 0.05 % | $ 25.4 B | ||
|
Abeona Therapeutics
ABEO
|
-2.76 | $ 5.07 | -5.5 % | $ 108 M |